| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Mucin glycoproteins in neoplasia.
|
Glycoconj J
|
1996
|
1.81
|
|
2
|
Aberrant O-linked oligosaccharide biosynthesis in lymphocytes and platelets from patients with the Wiskott-Aldrich syndrome.
|
J Biol Chem
|
1991
|
1.28
|
|
3
|
The relative activities of the C2GnT1 and ST3Gal-I glycosyltransferases determine O-glycan structure and expression of a tumor-associated epitope on MUC1.
|
J Biol Chem
|
2000
|
1.15
|
|
4
|
Infections with Pseudomonas aeruginosa in patients with cystic fibrosis.
|
Behring Inst Mitt
|
1997
|
1.14
|
|
5
|
O-glycan biosynthesis in human colorectal adenoma cells during progression to cancer.
|
Eur J Biochem
|
1994
|
1.09
|
|
6
|
High-performance liquid chromatography assays for N-acetylglucosaminyltransferases involved in N- and O-glycan synthesis.
|
Methods Enzymol
|
1989
|
1.06
|
|
7
|
Synthesis of O-glycan core 3: characterization of UDP-GlcNAc: GalNAc-R beta 3-N-acetyl-glucosaminyltransferase activity from colonic mucosal tissues and lack of the activity in human cancer cell lines.
|
Glycobiology
|
1995
|
1.05
|
|
8
|
Control of glycoprotein synthesis: substrate specificity of rat liver UDP-GlcNAc:Man alpha 3R beta 2-N-acetylglucosaminyltransferase I using synthetic substrate analogues.
|
Glycoconj J
|
1992
|
1.02
|
|
9
|
Alterations of O-glycan biosynthesis in human colon cancer tissues.
|
Glycobiology
|
1994
|
0.98
|
|
10
|
Altered expression of leucocyte sialoglycoprotein in Wiskott-Aldrich syndrome is associated with a specific defect in O-glycosylation.
|
Biochem Cell Biol
|
1989
|
0.96
|
|
11
|
Mucin synthesis. UDP-GlcNAc:GalNAc-R beta 3-N-acetylglucosaminyltransferase and UDP-GlcNAc:GlcNAc beta 1-3GalNAc-R (GlcNAc to GalNAc) beta 6-N-acetylglucosaminyltransferase from pig and rat colon mucosa.
|
Biochemistry
|
1985
|
0.92
|
|
12
|
A transfected sialyltransferase that is elevated in breast cancer and localizes to the medial/trans-Golgi apparatus inhibits the development of core-2-based O-glycans.
|
J Cell Biol
|
1997
|
0.89
|
|
13
|
Glycosylation patterns of mucins in colonic disease.
|
Biochem Soc Trans
|
1995
|
0.89
|
|
14
|
The biosynthesis of branched O-glycans.
|
Symp Soc Exp Biol
|
1989
|
0.87
|
|
15
|
Mucin synthesis. Conversion of R1-beta 1-3Gal-R2 to R1-beta 1-3(GlcNAc beta 1-6)Gal-R2 and of R1-beta 1-3GalNAc-R2 to R1-beta 1-3(GlcNAc beta 1-6)GalNAc-R2 by a beta 6-N-acetylglucosaminyltransferase in pig gastric mucosa.
|
Eur J Biochem
|
1986
|
0.86
|
|
16
|
Expression of stable human O-glycan core 2 beta-1,6-N-acetylglucosaminyltransferase in Sf9 insect cells.
|
Biochem J
|
1997
|
0.85
|
|
17
|
Oligosaccharide branching of glycoproteins: biosynthetic mechanisms and possible biological functions.
|
Philos Trans R Soc Lond B Biol Sci
|
1982
|
0.84
|
|
18
|
Processing O-glycan core 1, Gal beta 1-3GalNAc alpha-R. Specificities of core 2, UDP-GlcNAc: Gal beta 1-3 GalNAc-R(GlcNAc to GalNAc) beta 6-N-acetylglucosaminyltransferase and CMP-sialic acid: Gal beta 1-3GalNAc-R alpha 3-sialyltransferase.
|
Glycoconj J
|
1993
|
0.82
|
|
19
|
Primary human osteoblasts and bone cancer cells as models to study glycodynamics in bone.
|
Int J Biochem Cell Biol
|
2007
|
0.82
|
|
20
|
UDPgalactose:glycoprotein-N-acetyl-D-galactosamine 3-beta-D-galactosyltransferase activity synthesizing O-glycan core 1 is controlled by the amino acid sequence and glycosylation of glycopeptide substrates.
|
Eur J Biochem
|
1994
|
0.81
|
|
21
|
Synthesis of tetrasaccharide analogues of the N-glycan substrate of beta-(1-->2)-N-acetylglucosaminyltransferase II using trisaccharide precursors and recombinant beta-(1-->2)-N-acetylglucosaminyltransferase I.
|
Carbohydr Res
|
1994
|
0.80
|
|
22
|
Role of aberrant sialylation of chronic myeloid leukemia granulocytes on binding and signal transduction by chemotactic peptides and colony stimulating factors.
|
Leuk Lymphoma
|
1993
|
0.80
|
|
23
|
Characterization of a novel mucin sulphotransferase activity synthesizing sulphated O-glycan core 1,3-sulphate-Gal beta 1-3GalNAc alpha-R.
|
Glycobiology
|
1995
|
0.80
|
|
24
|
Increased activity of a specific sialyltransferase in chronic myelogenous leukemia.
|
Blood
|
1985
|
0.79
|
|
25
|
Synthetic substrate analogues for UDP-GlcNAc: Man alpha 1-3R beta 1-2-N-acetylglucosaminyltransferase I. Substrate specificity and inhibitors for the enzyme.
|
Glycoconj J
|
1995
|
0.78
|
|
26
|
Inhibition of UDP-GlcNAc:Gal beta 1-3GalNAc-R (GlcNAc to GalNAc) beta 6-N-acetylglucosaminyltransferase from acute myeloid leukaemia cells by photoreactive nitrophenyl substrate derivatives.
|
Biochem Biophys Res Commun
|
1994
|
0.77
|
|
27
|
Human serum-induced porcine endothelial cell apoptosis--another pathway to xenograft rejection.
|
Transplant Proc
|
1996
|
0.77
|
|
28
|
Mucin synthesis. III. UDP-GlcNAc:Gal beta 1-3(GlcNAc beta 1-6)GalNAc-R (GlcNAc to Gal) beta 3-N-acetylglucosaminyltransferase, an enzyme in porcine gastric mucosa involved in the elongation of mucin-type oligosaccharides.
|
Can J Biochem Cell Biol
|
1983
|
0.77
|
|
29
|
From imino sugars to cancer glycoproteins.
|
Glycoconj J
|
2003
|
0.77
|
|
30
|
Mucin synthesis. The action of pig gastric mucosal UDP-GlcNAc:Gal beta 1-3(R1)GalNAc-R2 (GlcNAc to Gal) beta 3-N-acetylglucosaminyltransferase on high molecular weight substrates.
|
Can J Biochem Cell Biol
|
1984
|
0.77
|
|
31
|
The action of TNFalpha and TGFbeta include specific alterations of the glycosylation of bovine and human chondrocytes.
|
Biochim Biophys Acta
|
2006
|
0.76
|
|
32
|
Synthetic substrate analogues for UDP-GlcNAc: Man alpha 1-6R beta(1-2)-N-acetylglucosaminyltransferase II. Substrate specificity and inhibitors for the enzyme.
|
Glycoconj J
|
1994
|
0.76
|
|
33
|
The separation by liquid chromatography (under elevated pressure) of phenyl, benzyl, and O-nitrophenyl glycosides of oligosaccharides. Analysis of substrates and products for four N-acetyl-D-glucosaminyl-transferases involved in mucin synthesis.
|
Carbohydr Res
|
1983
|
0.76
|
|
34
|
Preferred conformations and dynamics of five core structures of mucin type O-glycans determined by NMR spectroscopy and force field calculations.
|
Glycoconj J
|
1993
|
0.75
|
|
35
|
Human leukemic myeloblasts and myeloblastoid cells contain the enzyme cytidine 5'-monophosphate-N-acetylneuraminic acid:Gal beta 1-3GalNAc alpha (2-3)-sialyltransferase.
|
Cancer Res
|
1990
|
0.75
|
|
36
|
Presence of cytidine 5'-monophospho-N-acetylneuraminic acid:Gal beta 1-3GalNAc-R alpha(2-3)-sialyltransferase in normal human leukocytes and increased activity of this enzyme in granulocytes from chronic myelogenous leukemia patients.
|
Cancer Res
|
1987
|
0.75
|
|
37
|
[Synthesis of modified oligosaccharides of the N-glycoprotein as substrate for N-acetylglucosaminyltransferase I].
|
Carbohydr Res
|
1992
|
0.75
|
|
38
|
3rd International Workshop on Carcinoma-Associated Mucins, August 7-11 1994, Cambridge, UK.
|
Glycoconj J
|
1995
|
0.75
|
|
39
|
Immunochemistry of highly branched N-glycans. Terminal N-acetyl-D-glucosamine (GlcNAc) cluster antigens contain epitopes composed of terminal GlcNAc residues linked to mannose.
|
Biochem Cell Biol
|
1988
|
0.75
|
|
40
|
[Synthesis of modified tetrasaccharides as analog acceptor-inhibitors of N-acetylglucosaminyltransferase II].
|
Carbohydr Res
|
1995
|
0.75
|
|
41
|
Separation of neutral reducing oligosaccharides derived from glycoproteins by HPLC on a hydroxylated polymeric support.
|
Anal Biochem
|
1988
|
0.75
|
|
42
|
Human serum induces apoptosis of xenogenic cardiomyocytes in vivo and in vitro.
|
Xenotransplantation
|
2000
|
0.75
|
|
43
|
Activity of UDP-GlcNAc:GlcNAc beta 1-->6(GlcNAc beta 1-->2) Man alpha 1-->R[GlcNAc to Man] beta 1-->4N-acetylglucosaminyltransferase VI (GnT VI) from the ovaries of Oryzias latipes (Medaka fish).
|
Biochem Biophys Res Commun
|
1997
|
0.75
|